Robinson James A. Jr.
SEC insider (Form 3/4/5 filer). CIK 0001734295. Director at UroGen Pharma Ltd. (URGN) and 1 other issuer. 11 reported Form 4/5 transactions since Sep 2024; latest on Aug 26, 2026. Located in PRINCETON, NJ.
Companies Robinson James A. Jr. has filed insider reports for
- UroGen Pharma Ltd. (URGN): Director
- Eledon Pharmaceuticals, Inc. (ELDN): Director
Robinson James A. Jr.
CIK: 0001734295
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Jan 10, 2035ELDN
Eledon Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
30.9K shares- - Aug 26, 2026URGN
UroGen Pharma Ltd.
ExerciseDirect2K shares- - Jun 22, 2026URGN
UroGen Pharma Ltd.
AwardDirectRestricted Stock Unit
8K shares- - Jun 22, 2026URGN
UroGen Pharma Ltd.
AwardDirectStock Option (right ot buy)
10K shares- - May 26, 2026URGN
UroGen Pharma Ltd.
ExerciseDirect2K shares- - Jan 10, 2026ELDN
Eledon Pharmaceuticals, Inc.
ExerciseDirect3.4K shares- - Nov 26, 2025URGN
UroGen Pharma Ltd.
ExerciseDirect2K shares- - Aug 26, 2025URGN
UroGen Pharma Ltd.
AwardDirectStock Option (right ot buy)
10K shares- - Aug 26, 2025URGN
UroGen Pharma Ltd.
AwardDirectRestricted Stock Unit
8K shares- - Feb 26, 2025URGN
UroGen Pharma Ltd.
ExerciseDirect2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 10, 2035 |  ELDN Eledon Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 30,870 | - | - | Direct |
| Aug 26, 2026 |  URGN UroGen Pharma Ltd. | Exercise | 2,000 | - | $0 | Direct |
| Jun 22, 2026 | URGN UroGen Pharma Ltd. | Award Restricted Stock Unit | 8,000 | - | - | Direct |
| Jun 22, 2026 | URGN UroGen Pharma Ltd. | Award Stock Option (right ot buy) | 10,000 | - | - | Direct |
| May 26, 2026 | URGN UroGen Pharma Ltd. | Exercise | 2,000 | - | $0 | Direct |
| Jan 10, 2026 | ELDN Eledon Pharmaceuticals, Inc. | Exercise | 3,430 | - | $0 | Direct |
| Nov 26, 2025 | URGN UroGen Pharma Ltd. | Exercise | 2,000 | - | - | Direct |
| Aug 26, 2025 | URGN UroGen Pharma Ltd. | Award Stock Option (right ot buy) | 10,000 | - | - | Direct |
| Aug 26, 2025 | URGN UroGen Pharma Ltd. | Award Restricted Stock Unit | 8,000 | - | - | Direct |
| Feb 26, 2025 | URGN UroGen Pharma Ltd. | Exercise | 2,000 | - | $0 | Direct |
1-10 of 11 transactions